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ABSTRACT
Introduction Severe acute malnutrition (SAM) and 
disability are major global health issues. Although they can 
cause and influence each other, data on their co- existence 
are sparse. We aimed to describe the prevalence and 
patterns of disability among a cohort of children with SAM.
Methods A longitudinal cohort study in Malawi followed 
SAM survivors up to 7 years postdischarge. Clinical and 
anthropometric profiles were compared with sibling and 
community controls. Disability at original admission was 
identified clinically; at 7- year follow- up a standardised 
screening tool called ‘the Washington Group Questionnaire’ 
was used.
Results 60/938 (6.4%) of admissions to SAM treatment 
had clinically obvious disability at admission. Post- 
treatment mortality was high, with only 11/60 (18%) 
surviving till 7- year follow- up. SAM children with a 
disability at admission had 6.99 (95% CI 3.49 to 14.02; 
p<0.001) greater risk of dying compared with children 
without disability. They were also older, less likely to be HIV 
positive or have oedema and more severely malnourished. 
Long- term survivors were more stunted, had less catch- up 
growth, smaller head circumference, weaker hand grip 
strength and poorer school achievement than non- disabled 
survivors.
The Washington Group Questionnaire confirmed disability 
in all who had been identified clinically, and identified 
many who had not been previously flagged.
Conclusion Disability is common among children 
affected by SAM. Those with disability- associated SAM 
have greatly increased risk of dying even if they survive 
the initial episode of malnutrition. Survivors have poorer 
growth, physical strength and school achievement. To 
enable all children to survive and thrive post- SAM, it is vital 
to focus more on those with disabilities. SAM treatment 
programmes should consider using not just clinical 
assessment but structured assessments to better identify 
at- risk individuals as well as understand the population of 
children for which they are developing services.
INTRODUCTION
There is increasing international awareness 
of the links between malnutrition and disa-
bility: both are major global health problems, 
and both are key human rights concerns. 
Severe acute malnutrition (SAM) affects >14 
million children aged under 5 years world-
wide.1 Moderate or severe disability affects 
around 93 million children aged 0–14 years 
worldwide.2 However, links between these two 
global health problems in low- income settings 
are poorly understood and seldom consid-
ered by those working in the two respective 
fields.
Key questions
What is already known?
 ► Severe acute malnutrition (SAM) and disability are 
important global health issues.
 ► Although each can cause and influence the other, 
data on their co- existence are sparse.
What are the new findings?
 ► Disability is common among children affected by 
SAM, especially cerebral palsy and developmental 
delay.
 ► Children with SAM and underlying disability have 
greatly increased risk of death—almost 7 times 
greater risk compared with those who had SAM but 
no underlying disability.
 ► Clinical identification alone fails to identify many 
children with disability.
What do the new findings imply?
 ► To help children survive and thrive post- SAM, it is vi-
tal that those with underlying disability are identified 
and supported.
 ► SAM treatment programmes should consider using 
more structured assessments, such as screening 
tools, to better understand the population of children 
they are serving: clinical assessment alone is likely 
to be inadequate.
 ► Our findings concur with emerging evidence sug-
gesting that SAM programmes need to tailor 
treatment towards risk rather than severity of an-
thropometry only.
 ► As we consider the future of treatment programmes, 
it is imperative that identification and support for 
disability is included.
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Disability can be both caused by SAM and can result in 
a greater risk of SAM.3 Despite this knowledge, there is 
little data on the prevalence of children with both condi-
tions in low- resource settings, and the diagnosis and 
management of each condition often does not consider 
the other. This is compounded by the fact that many SAM 
research studies exclude children with disabilities from 
their sample or analysis.4
Our study cohort (the ‘Pronut’ cohort) were originally 
admitted to the child malnutrition ward in the Queen 
Elizabeth Central Hospital Blantyre, Malawi, for treat-
ment of SAM in 2006/2007.5 All admissions, including 
those with disabilities were enrolled. The cohort was 
followed- up at 1 year postdischarge (FuSAM study, 
follow- up post- SAM) and again at 7 years postdischarge 
(ChroSAM study, chronic disease outcomes post- SAM).6 7 
Since the advances in the treatment of SAM as well as a 
number of other important child health interventions, 
more children globally are surviving to see their fifth 
birthday. This has resulted in a considerable gap in our 
knowledge of both the short- term and long- term effects 
for SAM survivors.8 9 Even less is known about outcomes 
for children with disabilities due to challenges in diag-
nosis, measurements, and follow- up.
To fill some of the above evidence gaps, our aim was to 
use our SAM cohort from Malawi to describe the preva-
lence, characteristics and outcomes of disability among 
children with SAM. Objectives were to:
 ► describe the short- term and long- term post- SAM 
outcomes among children with disability compared 
with those with no underlying disability;
 ► explore two different methods of identifying disa-
bility among children with SAM: clinical assessment 
vs structured assessment using a validated tool.10
Understanding these basic issues will help inform 
future approaches and interventions for diagnosis, 
immediate management and long- term management of 
children with SAM who have a disability. It is also key to 
advocating for better malnutrition prevention strategies 
within this group.
METHODS
This was a secondary analysis arising from two longitudinal 
cohort studies prospectively following up survivors who 
had been treated for SAM, 1 and 7 years postdischarge 
from a hospital in Blantyre, Malawi. Non- SAM sibling and 
age- matched/sex- matched community controls were also 
recruited for at the 7- year follow- up.
Study setting and subjects
Full details of the cohort, as well as additional methods 
and results on other outcomes are described else-
where.5–7 11–14 In brief, the original cohort included all 
patients admitted to the nutrition ward of Queen Eliz-
abeth Central Hospital, Blantyre, Malawi, from 12 July 
2006 to 9 March 2007 (1024 children). At the time, 
Community Management of Acute Malnutrition was not 
available so all children were admitted to initial inpatient 
care but once clinically stable were followed up at fort-
nightly outpatient clinics. All admissions, including those 
with disabilities, were enrolled. The cohort was followed 
up at 1- year postdischarge and again at 7 years postdis-
charge.5–7 The median age at admission was 21.5 months 
(IQR 15–32 months). Results of survival and anthropom-
etry analysis at baseline and the 1- year follow- up have 
been described previously.5 6 Sibling controls were those 
closest in age to the SAM survivor (‘case child’), between 
the ages of 6 and 15.9 years; community controls were 
those living in the same community, of the same sex, 
and within 12 months of age of the case child, randomly 
selected by spinning a bottle at the case child’s home to 
select a random direction, then enquiring door- to- door to 
find the first eligible child. Children who had ever been 
treated for acute malnutrition were excluded from the 
control group. Informed written consent was obtained 
from the child’s parent or guardian; assent from the chil-
dren themselves.
Variables
At admission and each follow- up, we collected anthropo-
metric data (height, weight, mid- upper arm circumfer-
ence) using duplicate measures by two data collectors, 
following the method recommended by WHO.15 Weight- 
for- height (WHZ), weight- for- age (WAZ), height- for- age 
(HAZ) and body mass index (BMI)- for- age (BAZ) scores 
were calculated using WHO growth standards.16 At the 
7- year follow- up, we also measured waist circumference 
and hip circumference, and hand grip strength using a 
Takei Grip- D device (Takei, Niigata, Japan). School grade 
achieved was used as a measure of educational attain-
ment since children in Malawi do not move to the next 
grade until they pass, irrespective of their age. HIV status 
was established from results in health passports; or if 
unknown, an HIV test was offered by a trained counsellor. 
If a child had died, this had to be reported by the main 
caregiver. If the main caregiver could not be located, this 
was recorded as loss- to- follow- up. Whole- body bioelec-
trical impedance (Z, ohms) was measured with the child 
supine using a Quadscan 4000 device (Bodystat, Douglas, 
Isle of Man). The impedance index (HT2/Z) was calcu-
lated as an index of fat- free mass.
At original admission, a clinician (doctor or clinical 
offer) noted presence of any clinically obvious disability 
(eg, cerebral palsy (CP), Down syndrome). The diag-
nosis was confirmed by a senior paediatrician but details 
and severity were not further described at the time. 
At the 7- year follow- up, we used a formal assessment 
tool, the ‘Washington Group’ questions (questions 
1–6 from the Short Set with additional questions 7–14 
from the Extended Set (parent reported)).10 These 
explored physical and behaviour difficulties experi-
enced by children, as reported by their caregiver. We 
categorised questions 1–4 (difficulty seeing, hearing, 
walking or self- care) as ‘physical difficulties’, and the 
rest of the questions (5-14; difficulty understanding, 
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being understood, learning, remembering, worrying, 
controlling behaviour, completing tasks, change of 
routine, getting along with other children and diffi-
culty playing) as ‘behaviour and learning difficulties’. 
The questionnaire was administered by trained study 
nurses. The tool, a product of a UN Statistics working 
group, (The Washington Group on Disability Statis-
tics) has been widely validated in low- income, middle- 
income and high- income countries. It is currently used 
by National Statistics Offices in over 80 countries and 
has been identified as the primary methodology for 
disability statistics collection related to the Sustainable 
Development Goals, as well as being widely used in 
research studies ( www. washingtongroup. com).
Sample size and analysis
Sample size was predetermined by the cohort size and 
survival rates. Controls were more difficult to recruit 
throughout the study in comparison to cases because 
they had no previous personal connection with the study 
team and were restricted to the number of eligible chil-
dren in the family and community.
We used Stata V.14 to perform all analyses (StataCorp, 
College Station, Texas, USA). We included age, sex 
and HIV status as a priori potential confounders in all 
multivariable regressions. We used multivariable logistic 
regression and Kaplan- Meier survival curves to explore 
differences in survival between those with a clinically 
obvious disability and those without. We also used multi-
variable logistic regression for categorical outcomes and 
multivariable linear regression for continuous outcomes, 
to assess differences in admission characteristics between 
those with a clinically obvious disability and those without; 
differences in response to Washington Group questions 
between SAM survivors and control groups and differ-
ences in outcomes within the SAM survivors at 7 years 
postdischarge for children with versus without a clinically 
obvious disability, as well as those who had physical versus 
no physical difficulties based on the Washington Group 
questions, and those with behaviour versus no behaviour 
difficulties.
RESULTS
According to the original clinical assessment at admis-
sion for SAM treatment, 60/938 (6.4%) had an obvious 
disability. Three hundred fifty- two of the cohort were 
found to be alive at 1- year postdischarge, and 314 at 7 
years postdischarge. Of those with a clinically obvious 
disability:
 ► 18/60 (30%) were still known to be alive at 1- year 
follow- up, hence 18/352 (5.1%) of survivors had a 
disability at 1- year follow- up;
 ► 11/60 (18%) were still known to be alive at 7- year 
follow- up, hence 11/314 (3.5%) survivors have a disa-
bility at 7- year follow- up (42 had died and 7 were lost- 
to- follow up).
Table 1 describes the types of disabilities identified at 
admission, and details how many individuals progressed 
to each follow- up stage. Most children had CP or ‘devel-
opmental delay’.
Survival
Children with a (clinically identified) disability at 
admission had a much greater risk of dying by 7- year 
postdischarge compared with those admitted without 
a disability (figure 1) (unadjusted relative risk (RR) 
3.03 (95% CI 1.65 to 5.56; p<0.001); RR adjusted for 
age, sex and HIV status 6.99 (95% CI 3.49 to 14.02; 
p<0.001).
At the 1- year follow- up, we found a high mortality 
rate (42%) for children with SAM, both during treat-
ment and within 1 year of discharge from treatment. 
Two groups of children were particularly vulnerable: 
those with HIV, who made up 274 (62%) of the chil-
dren who died and those with disabilities who were HIV 
negative (n=15 (4%)), who were 2.8 times more likely 
to die during follow- up than children without disabili-
ties (95% CI 1.4 to 5.3).6 By year 7, children with disabil-
ities were 6.99 times more likely to die compared with 
non- disabled patients with SAM. As noted below, we 
also found long- term adverse effects on growth, body 
composition, muscle strength and school achievement, 
Table 1 Description of types of disability identified clinically at admission for SAM treatment
Type of disability
(as recorded in clinical notes)
Admission
(n=60) 1- year follow- up (n=18) 7- year follow- up (n=11)
Cerebral palsy 34 10 6
Down syndrome 1 1 1
Developmental delay 10 2 1
Musculoskeletal condition 1 1 1
Right hemiplegia 1 1 0
Hydrocephalus 3 0 0
Pierre Robin syndrome 1 0 0
Talipes (clubfoot) 1 0 0
Mild physical difficulty walking 1 0 0
Unspecified disability 7 3 2
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for SAM survivors compared with sibling and commu-
nity controls.7
Although the sample size is small, it is important to 
point out that in addition to overall increased mortality 
rates, children with some types of disability were at partic-
ular risk. By year 7, 82% of children with CP had died.
Differences between SAM admissions with and without a 
clinically obvious disability
Children with a clinically obvious disability were older 
on average and had a slightly higher proportion of males 
than children without a disability at admission (table 2). 
Those with a disability at admission were also less likely 
to be HIV positive and less likely to have oedema than 
children without a disability. At admission they also had 
a 1.31 lower mean WHZ score, 1.27 lower WAZ score and 
0.78 lower HAZ score (table 2 and online supplemental 
annex table 1). Adjusted OR for being HIV positive if a 
child had a disability, compared with no disability, was 
Figure 1 Kaplan- Meier survival curves, for those with 
disability versus no disability.
Table 2 Description of children with and without a clinically obvious disability in the sample
At original admission Clinically obvious disability n=60 No obvious disability n=878
Age (months) (median, IQR) 29 (14–55) 21 (15–31)
Males 38 (63.3%) 457 (52.3%)
Known HIV positive 13 (21.6%) 407 (46.4%)
Oedema 39 (65.0%) 618 (70.4%)
Weight (kg) (minimum on ward) (mean (SD)) 7.5 (3.4) 7.4 (2.6)
Length (cm) (mean (SD)) 77.7 (13.9) 76.2 (11.6)
MUAC (mean (SD)) 11.5 (2.5) 11.6 (2.0)
WHZ (mean (SD)) −3.55 (1.99) −2.70 (1.82)
WAZ (mean (SD)) −4.58 (1.55) −3.66 (1.61)
HAZ (mean (SD)) −4.11 (1.66) −3.37 (1.46)
At 7- year follow- up Clinically obvious disability n=11 No obvious disability n=303
Age (months) (median, IQR) 142 (124–151) 111 (103–122)
Males 8 (73%) 161 (53%)
Known HIV positive 2 (18.2%) 86 (28.4%)
Weight (kg) (mean (SD)) 26.0 (9.1) 23.9 (4.9)
Height (cm) (mean (SD)) 124.3 (17.0) 125.0 (9.0)
MUAC (mean (SD)) 179.6 (40.6) 172.1 (19.0)
BAZ (mean (SD)) −1.55 (0.41) −0.85 (0.94)
HAZ −3.40 (2.57) −1.80 (1.17)
HAZ gain since admission −0.33 (1.26) 1.42 (1.42)
Waist circumference 56.4 (7.2) 56.2 (4.2)
Hip circumference 63.6 (10.8) 62.3 (5.7)
Head circumference 51.1 (3.5) 51.8 (2.0)
Hand grip strength 9.62 (6.6) 12.7 (6.4)
Impedance index (HT2/Z) 24.4 (8.8) 21.3 (4.9)
School grade achieved 1.0 (1.8) 2.5 (1.2)
WAZ and WHZ at 7- year follow- up is not presented as children are too old for these reference (WHZ is only for children aged <5 years, WAZ 
only for children aged <11 years) (only 1 child with a disability was aged <11 years by 7- year follow- up).
BAZ, BMI- for- age z- score; BMI, body mass index; HAZ, height- for- age z- score; MUAC, mid- upper arm circumference; WAZ, weight- for- age 
z- score; WHZ, weight- for- height z- score.
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0.34 (95% CI 0.18 to 0.65; p=0.001), and for having nutri-
tional oedema at admission is 0.44 (95% CI 0.22 to 0.88; 
p=0.02).
At 7- year follow- up, those admitted with a clinically 
obvious disability had a significantly lower HAZ, HAZ 
gain since admission, waist circumference, hip circumfer-
ence, head circumference, hand grip strength and school 
achievement at 7- year postdischarge than those who were 
not diagnosed with a clinically obvious disability at admis-
sion (online supplemental annex figure 1 and table 2). 
As the growth references for WAZ is only applicable to 
children up to 11 years of age, and the SAM survivors with 
a disability tend to be older than those without regression 
was not conducted for WAZ. The small sample size of the 
SAM survivors with disabilities is also likely affecting the 
statistical significance of differences, since SAM survivors 
with a disability also have a lower mean BAZ compared 
with those without disabilities, but it is not statistically 
different.
Overlap between those diagnosed as having a clinically 
obvious disability and reported difficulties using the 
Washington Group questions
We found that all of those identified with a clinically 
obvious disability at admission were reported to have ‘a 
lot or more’ difficulty by at least one of the Washington 
Group questions at 7 years post- SAM (table 3). Only one 
of these clinically identified children did not have a lot 
of physical difficulty, but did identify as having significant 
learning and behavioural difficulties.
In contrast, many children without clinically obvious 
disability at original admission were identified as having 
problems at 7 years. This was particularly marked for 
learning/behavioural problems, with 30% (90/297) 
having a difficulty at 7 years that was not obvious at base-
line. There was also increased identification of children 
not previously clinically identified as having physical 
difficulties, with an additional 6% (19/297) of children 
reporting ‘a lot of difficulty’ with one or more physical 
activities at 7 years.
Prevalence of difficulties in survivors and controls using the 
Washington Group questions
Children reported having ‘at least some’ physical difficulty 
ranged from 0.6% of community controls (walking) to 
16.6% of SAM survivors (hearing) (online supplemental 
annex table 2). Of the behavioural difficulties, the highest 
prevalence was for ‘difficulty remembering’ among the 
SAM survivors (32.6%) and the lowest prevalence was for 
‘difficulty being understood’ among the sibling controls 
(2.4%). Figure 2 (and online supplemental annex table 
3) presents a summary of prevalence for ‘any physical 
difficulty’, ‘any behavioural difficulty’ and ‘any difficulty’, 
as well as the same categories for those who were catego-
rised as ‘a lot of difficulty’ or greater.
Are there differences in responses to the Washington 
Group questions for SAM survivors compared with 
controls?
Crude analysis shows that sibling controls had signifi-
cantly lower odds of having a behavioural difficulty, any 
difficulty, a lot of physical difficulty, a lot of learning/
behaviour difficulty and a lot of any difficulty, than SAM 
survivors (after adjusting for age, sex and HIV) (table 4). 
Community controls had similar odds of having difficul-
ties compared with SAM survivors, except for ‘a lot of 
physical difficulty’ where odds were significantly lower 
for community controls compared with SAM survivors.
Applying multivariable logistic regression to adjust for 
age, sex and HIV status, we found that sibling controls 
have significantly reduced odds of difficulty hearing, 
understanding, being understood, learning, remem-
bering and completing tasks, compared with SAM survi-
vors (online supplemental annex table 4). None of the 
questions was significantly different when comparing 
SAM survivors with community controls. When applying 
the same analysis, but for ‘a lot or more’ difficulty to all 
Table 3 Differences between disability diagnosis at admission and ‘a lot of difficulty’ identified by Washington Questions* at 
7 years postdischarge (SAM survivors only)
Identified as having a 
disability at admission
(n=11 survivors)
Not identified as having 
disability at admission 
(n=297 survivors)
Reported ‘a lot’ of physical difficulty at follow- up 10 (91%) 19 (6.4%)
Reported ‘a lot’ of learning/behaviour difficulties at follow- up 10 (91%) 90 (30.3%)
Reported ‘a lot’ of any difficulty at follow- up 11 (100%) 96 (32.3%)
*Options for responses to the questionnaire are: ‘no difficulty’, ‘some difficulty’, ‘a lot of difficulty’ and ‘cannot do at all’; these results show 
any children whose caregiver reported ‘a lot of difficulty’ or ‘cannot do at all’.
Figure 2 Bar chart showing prevalence of disabilities based 
on Washington Group questions at 7- year follow- up. SAM, 
severe acute malnutrition.
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of the questions, siblings had significantly reduced odds 
of difficulty hearing, understanding, remembering and 
controlling their behaviour. Community controls had 
significantly reduced odds of having difficulty hearing, 
and difficulty remembering. No community controls 
reported a lot of difficulty seeing or walking, compared 
with 5/314 and 10/314, respectively for SAM survivors.
Other associations with Washington Group questions
In the whole sample, HIV- positive children were signifi-
cantly more likely to have behavioural difficulties (after 
adjusting for SAM survival, age and sex=OR 1.75, 95% CI 
1.05 to 2.93, p=0.03), physical difficulties (OR 2.46, 
95% CI 1.48 to 4.09, p=0.001), and ‘any difficulty’ (OR 
1.84, 95% CI 1.07 to 3.16, p=0.03), compared with HIV- 
negative children. Boys reportedly worried more often 
than girls (OR 1.56, 95% CI 1.07 to 2.27, p=0.02). There 
was no association between any of the difficulty questions 
and age.
For growth and other outcomes, the SAM survivors clas-
sified as having ‘a lot or more difficulty’ with any of the 
physical indicators in the Washington Group questions, 
had a significantly lower HAZ, WAZ, waist circumfer-
ence and school achievement than those without a lot of 
physical difficulty. Only two outcomes were significantly 
different between those with ‘a lot of behavioural diffi-
culty’ and those without: waist circumference and school 
achievement (table 5).
DISCUSSION
Our study provides important insights into the prevalence 
and implications of having SAM with a disability; 6.4% of 
children admitted to a SAM treatment ward in Malawi 
had a clinically obvious disability, the most common 
being CP. They had a different phenotype compared with 
those without a disability and were older, less likely to be 
HIV positive or have oedema; and were more severely 
malnourished at admission. A key finding of our study is 
that they were also at significantly greater risk of dying, 
both during treatment and after discharge: only 11 of the 
original 60 children were known to have survived until 7 
years post- SAM.
The mortality risk is striking. By 7 years post- treatment, 
children with disabilities have almost seven times greater 
risk of dying than those without a disability. Mortality for 
children with two specific types of disabilities, CP and 
hydrocephalus is particularly high. While life expectancy 
for both conditions depends on the severity of the condi-
tion and co- existing medical concerns, this mortality is 
nonetheless, reason for further inquiry.
The second key observation is a marked difference 
in clinically obvious versus screening- tool identified 
disability. While a structured assessment tool such as 
Washington Group Questionnaire confirms disabilities 
identified clinically, many who were not originally identi-
fied as having a disability did have ‘difficulties’ at 7 years 
post- SAM (though the timing of onset of these difficulties 
is not possible to say from our data).
We know that children with disabilities are more vulner-
able to malnutrition for a variety of reasons, including: 
physical difficulties in feeding or swallowing (eg, among 
children with CP), receiving less food or less nutritious 
food at the household level3 17 or exclusion from feeding 
programmes.18 19 Our study confirms this increased 




Sibling controls vs 
SAM survivors
OR




(95% CI) P value
Sibling controls vs 
SAM survivors
OR
(95% CI) P value
Community 
controls vs SAM 
survivors
OR








0.56 (0.39 to 0.79) 0.001 1.27 (0.85 to 1.91) 0.24 0.62 (0.41 to 0.93) 0.02 1.33 (0.85 to 2.11) 0.22
Any difficulty 0.51 (0.36 to 0.74) <0.001 1.38 (0.90 to 2.10) 0.14 0.59 (0.36 to 0.89) 0.01 1.48 (0.92 to 2.39) 0.11
‘A lot’ of physical 
difficulty
0.34 (0.15 to 0.79) 0.01 0.17 (0.05 to 0.57) 0.004 0.30 (0.11 to 0.85) 0.02 0.23 (0.06 0.86) 0.03




0.43 (0.28 to 0.66) <0.001 0.93 (0.62 to 1.38) 0.71 0.50 (0.31 to 0.80) 0.004 1.08 (0.68 to 1.72) 0.73
‘A lot’ of any 
difficulty
0.43 (0.28 to 0.66) <0.001 0.89 (0.60 to 1.31) 0.54 0.51 (0.32 to 0.81) 0.004 1.07 (0.68 to 1.69) 0.77
Logistic regression, both unadjusted and adjusted for age, sex and HIV status. P values <0.05 are statistically significant (in bold).
SAM, severe acute malnutrition.
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vulnerability in this population, and these same factors 
may also make them more likely to die as a consequence 
of malnutrition. Since ours was an observational trial, it is 
not possible to definitively infer causality and which came 
first, especially as the links between malnutrition and 
disability are bidirectional.20 An important outstanding 
question is how children with disabilities and SAM 
compare with their peers with similar disabilities but who 
receive adequate nutrition.
Despite the small sample of survivors with a disability, 
we found that those in our study admitted with a clin-
ically obvious disability were more stunted, had less 
catch- up growth and had smaller waist, hip and head 
circumference than SAM survivors without a disability by 
7 years postdischarge. They also had functional deficits, 
including significantly weaker hand grip strength, and 
poor school achievement at 7 years postdischarge than 
those without a clinically obvious disability at admission. 
These are similar issues seen in SAM survivors compared 
with controls,7 but are even more severe in SAM survivors 
with disabilities.
Another significant finding is the additional value 
that a structured disability questionnaire such as the 
Washington Group tool can provide over and above 
Table 5 Differences in outcomes for children with and without difficulties at 7 years postdischarge (identified by WGQ)
A lot of any physical ‘difficulty’ (identified at 7- year 
follow- up by WGQ)
A lot of any learning/behavioural ‘difficulty’ (identified at 

















HAZ −1.76 (1.15) −2.46 (1.60) −0.52
(−1.04 to 0.01)
0.05
−1.77 (1.21) −1.88 (1.18) −0.09
(−0.37 to 0.19)
0.55
WAZ −1.50 (0.92) −2.24 (1.18) −0.74
(−1.31 to –0.18)
0.01
−1.51 (0.93) −1.62 (1.00) −0.12
(−0.40 to 0.16)
0.41
BAZ −0.83 (0.94) −1.15 (0.92) −0.25
(−0.68 to 0.18)
0.25
−0.83 (0.96) −0.91 (0.88) −0.07
(−0.30 to 0.16)
0.55
MUAC 172.4 (18.6) 175.2 (27.5) −2.6
(−9.9 to 4.7)
0.49
173.3 (19.4) 171.2 (19.5) −3.02
(−7.21 to 1.17)
0.16
WAZ gain since 
admission
1.73 (1.46) 1.31 (1.40) −0.20
(−1.00 to 0.60)
0.62
1.76 (1.50) 1.57 (1.36) −0.16
(−0.56 to 0.23)
0.41
HAZ gain since 
admission
1.41 (1.28) 1.19 (1.54) −0.001
(−0.63 to 0.63)
0.99





56.3 (4.1) 56.5 (5.8) −1.56
(−3.12 to –0.01)
0.04
59.5 (4.1) 55.8 (4.5) −0.99
(−1.90 to –0.10)
0.03
Hip circumference 62.3 (5.7) 63.3 (7.2) −1.01
(−3.07 to 1.06)
0.34





51.8 (2.1) 51.8 (2.1) −0.71
(−1.56 to 0.15)
0.10
51.9 (2.1) 51.7 (1.9) −0.33
(−0.82 to 0.16)
0.19
Hand grip strength 12.8 (6.4) 12.3 (5.2) −2.09
(−4.79 to 0.60)
0.13





21.4 (4.8) 21.5 (6.4) −1.90
(−3.87 to 0.07)
0.06





2.5 (1.3) 1.7 (1.6) −0.96
(−1.44 to –0.48)
<0.001
2.6 (1.2) 2.1 (1.3) −0.44
(−0.72 to –0.17)
0.002
Linear regression adjusted for age, sex and HIV status. We could not assess differences in WAZ for children with a clinically obvious disability 
as only one child has a valid WAZ since it can only be calculated for children aged <11 years. Although mean circumferences appear similar, a 
significant difference emerges after adjusting for age, as children with disabilities are significantly older than children without. P values <0.05 are 
statistically significant (in bold).
BAZ, BMI- for- age z- score; BMI, body mass index; HAZ, height- for- age z- score; MUAC, mid- upper arm circumference; SAM, severe acute 
malnutrition; WAZ, weight- for- age z- score; WGQs, Washington Group Questionnaire.
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clinical assessment for disability. Although the Wash-
ington Groups questions are not a diagnostic tool, they 
do provide insight into the presence and severity of phys-
ical or learning/behavioural difficulties. We found 100% 
overlap between those diagnosed with a disability clinically 
at admission and those with ‘a lot or more’ of any diffi-
culty, using the Washington Group questions. However, 
there were many children with ‘a lot or more’ physical 
difficulties that were not identified at original admission 
(6%), and an even greater number (30%) of children 
with ‘a lot or more’ learning/behavioural difficulties 
who were not identified at admission. Some of these diffi-
culties may have been new, acquired postadmission but 
a more likely explanation is that they were present but 
missed during non- specific clinical assessment. This high-
lights the utility of the Washington Group questions and 
underscores the need for formal assessment and better 
training on identification of disability within malnutri-
tion care. If a disability is never identified then opportu-
nities to properly support that child and his/her family 
are correspondingly limited.
Several recent studies relating to the treatment of acute 
malnutrition have suggested that programmes will be 
able to more effectively treat children if they focus on 
identifying the most ‘at- risk’ children, which may not 
simply be the most severely wasted children. For example, 
children who are concurrently wasted and stunted are at 
greater risk than those who are only wasted.20 Younger 
infants, especially those <6 months old, as well as some 
moderately malnourished children are also likely to be 
at high risk of death and deterioration.21 22 Our results 
concur with this concept and urge policymakers and 
practitioners to include disability while considering the 
future of SAM treatment programmes.
Comparing the Washington Group questions for SAM 
survivors with controls, we found that sibling controls had 
few physical and behaviour difficulties, whereas commu-
nity controls had similar behaviour difficulties to SAM 
survivors but fewer physical difficulties. The lower prev-
alence of difficulties reported by caregivers for sibling 
controls could be due to the relative and direct compar-
ison with the SAM surviving child. It is not possible to 
know whether the caregivers therefore reported greater 
relative difficulties in their SAM surviving child, or fewer 
relative difficulties in their sibling. Our recent study of 
cognitive function and brain MRI scans for this same 
group found apparent preservation in gross brain struc-
ture in SAM survivors compared with controls, however 
they did have reduced school achievement and weak 
evidence of poorer performance on a cognitive func-
tion test.13 We discussed whether poorer school achieve-
ment for SAM survivors could be due to the perception 
of stunted children, who may appear younger than they 
are, affecting when they are enrolled in school, when 
they move up grades and their social interactions with 
adults.23 24 Whether the greater difficulties in SAM 
survivors are biological or perceived, they have equally 
important functional implications.
Limitations
Although many impacts of disabilities were found by this 
study, we acknowledge that false negative results could be 
explained by the large survivor bias within our sample. 
This applies to the group of SAM survivors compared 
with controls, as well as to SAM survivors with a disability. 
If the mortality rate of children with SAM and a disability 
were reduced, and more children survive, even greater 
long- term morbidity/functional impairments within the 
population are likely. It was also difficult to achieve accu-
rate measurements for anthropometry and bioelectrical 
impedance analysis for some children with disabilities 
resulting in a small and potentially biased sample. We did 
not use modified processes for conducting anthropom-
etry in this population and we did not compared with 
specialised growth charts for children with CP.
Another limitation of our study is potential selec-
tion bias of our community control group. While the 
study team employed a systematic random method for 
selecting a child in the community of the same age and 
sex as the case child, they were reliant on households 
volunteering their eligible child to take part, or referring 
them to eligible neighbours. Children with more severe 
disabilities may have been less likely to be volunteered 
to our study team. Also possible is that those with prob-
lems were more likely to accept a clinical review (healthy 
neighbours maybe did not see the point of being assessed 
by our team of nurses)—this might explain the high rates 
of reported problems according to Washington Ques-
tions in our control group. Reporting bias with regard to 
comparison between SAM surviving children and their 
siblings may also be an issue, as already discussed. Lastly, 
it is important to note that, as an observational trial, it is 
not possible to determine causality and direction of rela-
tionship: whether disability or malnutrition came first.25
Finally, data for this cohort were collected using the 
Washington Group questions prior to development and 
adoption by a joint UNICEF/Washington Group task 
force of the Child Functioning Module (CFM). The CFM 
has two components: a module for children 2–4 years of 
age composed of 16 questions covering 8 core domains 
of functioning, and a module for children 5–17 years of 
age composed of 24 questions covering 12 core domains 
of functioning. Our findings remain valid, but future 
research using the CFM may produce more nuanced 
insight into SAM in children with disabilities.22
CONCLUSION
Mortality among children with disabilities at 1 and 7 years 
postdischarge was markedly higher than for non- disabled 
children admitted with SAM. Disability is second only to 
HIV as a risk factor for death—yet resources available for 
these two conditions differ hugely. Underlying disability 
was prevalent in a population of children with SAM, and 
those with a disability have even poorer growth, strength 
and school achievement than other SAM survivors. These 
results highlight the need for malnutrition prevention, 
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treatment and long- term support for children with disa-
bilities. Interventions to reduce the high postdischarge 
mortality of children with disabilities is a priority. Also 
vital is better support to improve development and in 
turn, school achievement. To better help all SAM survi-
vors to both survive and thrive, SAM programmes, as well 
as research studies, must become better at identifying 
and including children with disabilities. The Washington 
Group questions could be a simple, practical indicator for 
community programmes to better understand the popu-
lation of children they are serving. Improving structured 
assessments of children through tools and better training 
could also help identify these vulnerable children.
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